Next Article in Journal
Cloning and Molecular Characterization of HSL and Its Expression Pattern in HPG Axis and Testis during Different Stages in Bactrian Camel
Next Article in Special Issue
ADAM10 and ADAM17 as Biomarkers Linked to Inflammation, Metabolic Disorders and Colorectal Cancer
Previous Article in Journal
The Leucocyte Telomere Length, GSTM1 and GSTT1 Null Genotypes and the Risk of Chronic Obstructive Pulmonary Disease
Previous Article in Special Issue
Exploring the Novel Computational Drug Target and Associated Key Pathways of Oral Cancer
 
 
Brief Report
Peer-Review Record

Molecular Profiling of Tumor Tissue in Mexican Patients with Colorectal Cancer

Curr. Issues Mol. Biol. 2022, 44(8), 3770-3778; https://doi.org/10.3390/cimb44080258
by Beatriz Armida Flores-López 1, María de la Luz Ayala-Madrigal 1, José Miguel Moreno-Ortiz 1, Jorge Peregrina-Sandoval 2, Miguel Ángel Trujillo-Rojas 1, José Luis Venegas-Rodríguez 1, Rosario Hernández-Ramírez 1, Martha Alejandra Fernández-Galindo 1 and Melva Gutiérrez-Angulo 1,3,*
Reviewer 2: Anonymous
Curr. Issues Mol. Biol. 2022, 44(8), 3770-3778; https://doi.org/10.3390/cimb44080258
Submission received: 13 July 2022 / Revised: 11 August 2022 / Accepted: 17 August 2022 / Published: 20 August 2022
(This article belongs to the Special Issue Advances in Molecular Pathogenesis Regulation in Cancer)

Round 1

Reviewer 1 Report

This is an interesting paper aiming to identify novel gene variants in colorectal cancer patients.

Although the data are worth to publish there is a general problem with the four patients that have been selected for analysis.

3 patients have rectal tumors, patient 1 is left sided colon tumor. Two patient have hereditary background. According to the current knowledge in the field they all take another carcinogenesis pathway.

i recommend to repeat the data analysis to get useful and more reliable results..

patients 2-4 have to be compared to patient 1. when combining all 4 patients many genes were excluded because of patient 1. Give a Venn diagram to show overlaps between the patients. Finally consider and compare hereditary versus sporadic.

the patient selection has to be discussed in the Discussion part, clearly comparing rectal and colon signature based on their own data and based on the literature, the authors should exactly define which genes have been identified as novel and they should give this also in the abstract

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

In the present manuscript the authors are checking for genetic variants in tumor tissue from colorectal cancer patients. The subject is of interest for the oncology field and the study presented can give more information in the field, however there are some issues that need to be addressed.

The paper needs to be read querfully. There are some parts were the information is not so clear.

Also, for the introduction section, the authors need to give some more details related to the advantages of their proposed method.

Finally, do the authors have tried to check the same genes for one patient which rcieved a negative results after the biopsy was checked, as a control?

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

The authors answered adequately and sufficiently to the questions. The new discussion part includes very important new information regarding rectal origin of samples.

Reviewer 2 Report

The authors have made the changes asked and the quality of the manuscript improved. The manuscript can be published in the present form.

Back to TopTop